The standard of care for treating vestibular dysfunction is long overdue for a technological breakthrough.
Traditional vestibular therapy relies on manual techniques that demand significant patient effort and participation. Outcomes are limited by the patient’s physical and cognitive abilities—and by the therapist’s ability to deliver consistent, precise care. These limitations reduce therapeutic efficiency, intensity, and efficacy; introduce safety risks; and lead to prolonged recovery times and suboptimal outcomes. For millions of Americans with mobility or cognitive impairments, manual therapy becomes even more difficult—and in many case, impossible to administer.
While most fields of medicine have advanced through technology, vestibular rehabilitation has remained virtually unchanged—until now.
GyroStim's technological advantage changes everything.
GyroStim eliminates the inherent limitations of manual therapy. Its computer-controlled platform delivers automated, data-driven, high-intensity vestibular rehabilitation with unmatched precision and consistency. The result: therapy that is safer, more accessible, and more effective than any other available treatment.
GyroStim is the first and only vestibular treatment device to receive the FDA’s Breakthrough Device designation—recognizing its technological superiority and its potential to deliver significantly better outcomes than the outdated standard of care.